Guangdong Qianhui Biotechnology

Guangdong Qianhui Biotechnology is a specialized high-tech enterprise focused on the research, development, and large-scale production of pharmaceutical excipients, particularly cyclodextrin derivatives. The company is a leading Chinese manufacturer of Hydroxypropyl-beta-cyclodextrin and Sulfobutyl ether-beta-cyclodextrin sodium, which are essential for enhancing the solubility, stability, and bioavailability of poorly water-soluble drugs. Their manufacturing facilities are GMP-compliant, and their core products hold Drug Master File (DMF) registrations with both the US FDA and China's NMPA. Qianhui Biotechnology serves a global clientele, providing high-purity materials for injectable, oral, and topical pharmaceutical formulations.